Cancer Treatment Trial Hailed As 'Breakthrough'

The video discusses a successful immunotherapy treatment where 12 patients experienced complete cancer remission. The treatment, an immune checkpoint inhibitor, was part of a phase two trial targeting early-stage rectal cancer with microsatellite instability high tumors. The therapy is FDA-approved for several cancers, including colorectal and melanoma. The discussion highlights the potential to avoid radiation and surgery, ongoing trials, and the broader implications for cancer treatment. The video emphasizes scientific progress and encourages participation in clinical trials.

What are the potential next steps in the research of this treatment?

What is the significance of microsatellite instability in relation to this treatment?